Category - Executive Moves

Executive Moves

Pipeline Therapeutics appoints Eef Schimmelpennink to board

Evert Schimmelpennink Closely-held Pipeline Therapeutics named Evert (Eef) Schimmelpennink to its board. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research...

February 22, 2022

Executive Moves

Hepion names world-renowned hepatologist, Dr. Eddie Cheung, to lead strategic medical affairs in Asia

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed Eddie Cheung, M.D., FACG, to lead the company’s strategic medical affairs in Asia, a newly-created position. Dr. Cheung will explore and identify possible...

February 15, 2022

Executive Moves

Altamira updates RNA therapeutics program with new CDO, NIH grant

Altamira Therapeutics (NASDAQ:CYTO), in a business update on its development activities in RNA therapeutics, appointed Covadonga Pañeda, Ph.D., as chief development officer for RNA therapeutics, effective in early April...

January 13, 2022

Executive Moves

Global medical device executive Kenneth Knudson joins Profound as CCO

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed accomplished global medical device industry veteran, Kenneth Knudson, as chief commercial officer to lead Profound’s worldwide sales, marketing and reimbursement...

January 5, 2022

Executive Moves

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Ondine Biomedical (LSE:OBI), appointed Prof. Trevor Jones, CBE FMedSci, to lead a new advisory board on the use of its pioneering photodisinfection-based technology to prevent and treat COVID-19. Ondine’s non-antibiotic...

December 15, 2021

Executive Moves

Talkiatry appoints Vanessa Cao as SVP of operations

In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...

November 17, 2021

Executive Moves

Labster names Hope Frank as CMO

Hope Frank Closely-held Labster, a virtual learning platform for students, named Hope Frank as chief marketing officer as part of its continued mission to bring accessible and transformative STEM education (science...

November 17, 2021

Executive Moves

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

Ezekiel Emanuel Closely-held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the...

November 16, 2021

Executive Moves

GeneTether bolsters management team to support growth

Closely-held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development. The appointments are intended to further position...

October 19, 2021

Executive Moves

Daniel Pearlstein joins POINT Biopharma in corporate strategy

Daniel Pearlstein was named associate director, corporate strategy, of POINT Biopharma (NASDAQ:PNT), which debuted on the Nasdaq Capital Market on July 1, 2021. Mr. Pearlstein was formerly EVP for...

September 27, 2021

Category - Executive Moves

Pipeline Therapeutics appoints Eef Schimmelpennink to board

Hepion names world-renowned hepatologist, Dr. Eddie Cheung, to lead strategic medical affairs in Asia

Altamira updates RNA therapeutics program with new CDO, NIH grant

Global medical device executive Kenneth Knudson joins Profound as CCO

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Talkiatry appoints Vanessa Cao as SVP of operations

Labster names Hope Frank as CMO

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

GeneTether bolsters management team to support growth

Daniel Pearlstein joins POINT Biopharma in corporate strategy

General

More